Evaxion Biotech A/S (EVAX) Earnings Date & Reports

Evaxion Biotech AS is a clinical-stage biotech company that aspires toÂ the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

EVAX is expected to report earnings to fall 19.05% to -17 cents per share on April 02

Evaxion Biotech A/S EVAX Stock Earnings Reports

Q4'23

Est.

$-0.17

Q3'23

Missed

by $0.02

Q2'23

Beat

by $0.01

Q1'23

Beat

by $0.02

Q4'22

Missed

by $0.03

The last earnings report on December 19 showed earnings per share of -20 cents, missing the estimate of -18 cents. With 24.22K shares outstanding, the current market capitalization sits at 10.49M.

View a ticker or compare two or three

Compare

EVAX